Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. Wyatt CM, Drueke TB. Kidney Int 2020;97:639-642.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Wyatt CM, Drueke TB. Inhibition of HIF prolyl-hydroxylase domain to correct anemia in patients with chronic kidney disease. Kidney Int 2020;97:639-642.
PMID: 32200855